Combined effects of laser-ICG photothermotherapy and doxorubicin chemotherapy on ovarian cancer cells

Journal of Photochemistry and Photobiology B: Biology

Volumn 97, Issue 3, 2009, Pages 138-144

  Tang, Yuan ^a   McGoron, Anthony J ^a  

^a The Department of Electrical and Computer Engineering   (United States)

Author keywords

Anthracycline; Cytotoxicity; Doxorubicin; Hyperthermia; Indocyanine green; Near infrared laser

Indexed keywords

DOXORUBICIN; INDOCYANINE GREEN;

ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER RESISTANCE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; HEATING; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; IC 50; INCUBATION TEMPERATURE; LASER THERMOTHERAPY; OVARY CANCER; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE; COLORING AGENTS; DOXORUBICIN; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INDOCYANINE GREEN; LASERS; OVARIAN NEOPLASMS; PHOTOTHERAPY; TEMPERATURE;

EID: 71549140952     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2009.09.001     Document Type: Article

References (40)

1. Simpson C.R., et al. Near-infrared optical properties of ex vivo human skin and subcutaneous tissues measured using the Monte Carlo inversion technique. Phys. Med. Biol. 43 9 (1998) 2465-2478
2. Weissleder R., et al. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat. Biotechnol. 17 4 (1999) 375-378
3. Intes X., et al. In vivo continuous-wave optical breast imaging enhanced with Indocyanine Green. Med. Phys. 30 6 (2003) 1039-1047
4. Chen W.R., et al. Chromophore-enhanced in vivo tumor cell destruction using an 808-nm diode laser. Cancer Lett. 94 2 (1995) 125-131
5. Selawry O.S., Goldstein M.N., and Mc C.T. Hyperthermia in tissue-cultured cells of malignant origin. Cancer Res. 17 8 (1957) 785-791
6. van der Zee J. Heating the patient: a promising approach?. Ann. Oncol. 13 8 (2002) 1173-1184
7. Hahn G.M., Braun J., and Har-Kedar I. Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation. Proc Natl Acad Sci USA 72 3 (1975) 937-940
8. Helm C.W., et al. Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma. Gynecol. Oncol. 105 1 (2007) 90-96
9. Wydra D., et al. Combination of intraperitoneal hyperthermic perfusion chemotherapy (IHPC) with intraperitoneal chemotherapy as a treatment modality for persistent ovarian cancer. Eur. J. Gynaecol. Oncol. 28 2 (2007) 128-130
10. Koukourakis M.I., et al. Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer. J. Clin. Oncol. 17 11 (1999) 3512-3521
11. Park J.W., et al. Tumor targeting using anti-her2 immunoliposomes. J. Control. Release 74 1-3 (2001) 95-113
12. Gipps E.M., et al. Distribution of polyhexyl cyanoacrylate nanoparticles in nude mice bearing human osteosarcoma. J. Pharm. Sci. 75 3 (1986) 256-258
13. Brasseur F., et al. Actinomycin D absorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumor. Eur. J. Cancer 16 11 (1980) 1441-1445
14. Monks A., et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst. 83 11 (1991) 757-766
15. Ho J.D., et al. Cytotoxicity of indocyanine green on retinal pigment epithelium: implications for macular hole surgery. Arch. Ophthalmol. 121 10 (2003) 1423-1429
16. Skrivanovâa K., et al. Photochemical properties of a potential photosensitiser indocyanine green in vitro. Journal of photochemistry and photobiology. B, Biology 85 2 (2006) 150-154
17. Kodjikian L., et al. Toxic effects of indocyanine green, infracyanine green, and trypan blue on the human retinal pigmented epithelium. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fèur klinische und experimentelle. Ophthalmologie 243 9 (2005) 917-925
18. Rhee H.K., et al. Synthesis, cytotoxicity, and DNA topoisomerase II inhibitory activity of benzofuroquinolinediones. Bioorg. Med. Chem. 15 4 (2007) 1651-1658
19. Pastorino F., et al. Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin. J. Control. Release 126 1 (2008) 85-94
20. Hu F.Q., et al. Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin. Eur. J. Pharm. Biopharm. 69 1 (2008) 117-125
21. Urano M., Begley J., and Reynolds R. Interaction between adriamycin cytotoxicity and hyperthermia: growth-phase-dependent thermal sensitization. Int. J. Hyperther. 10 6 (1994) 817-826
22. Rice G.C., and Hahn G.M. Modulation of adriamycin transport by hyperthermia as measured by fluorescence-activated cell sorting. Cancer Chemother. Pharmacol. 20 3 (1987) 183-187
23. Supino R., et al. Interaction of heat with chemotherapy in vitro: effect on cell viability and protein synthesis in human and murine cell lines. Tumori 73 2 (1987) 109-116
24. Herman T.S., et al. Effect of heating on lethality due to hyperthermia and selected chemotherapeutic drugs. J. Natl. Cancer Inst. 68 3 (1982) 487-491
25. Engin K., et al. Thermoradiotherapy in the management of superficial malignant tumors. Clin. Cancer Res. 1 2 (1995) 139-145
26. Hildebrandt B., et al. The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol. Hematol. 43 1 (2002) 33-56
27. Christophi C., et al. The treatment of malignancy by hyperthermia. Surg. Oncol. 7 1-2 (1998) 83-90
28. Urano M. Kinetics of thermotolerance in normal and tumor tissues: a review. Cancer Res. 46 2 (1986) 474-482
29. Li G.C., Mivechi N.F., and Weitzel G. Heat shock proteins, thermotolerance, and their relevance to clinical hyperthermia. Int. J. Hyperthermia 11 4 (1995) 459-488
30. Kampinga H.H. Hyperthermia, thermotolerance and topoisomerase II inhibitors. Br. J. Cancer 72 2 (1995) 333-338
31. Chin K.V., et al. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem. 265 1 (1990) 221-226
32. Hevâer-Szabâo A., et al. P-glycoprotein is overexpressed and functional in severely heat-shocked hepatoma cells. Anticancer Res. 18 4C (1998) 3045-3048
33. Wartenberg M., et al. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular prostate tumor spheroids by hyperthermia and reactive oxygen species. Int. J. Cancer 113 2 (2005) 229-240 Journal international du cancer
34. Desmettre T., Devoisselle J.M., and Mordon S. Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. Surv. Ophthalmol. 45 1 (2000) 15-27
35. Alacam B., et al. Extended kalman filtering for the modeling and analysis of ICG pharmacokinetics in cancerous tumors using NIR optical methods. IEEE Trans. Biomed. Eng. 53 10 (2006) 1861-1871
36. Cuccia D.J., et al. In vivo quantification of optical contrast agent dynamics in rat tumors by use of diffuse optical spectroscopy with magnetic resonance imaging coregistration. Appl. Optics 42 16 (2003) 2940-2950
37. Owens S.L. Indocyanine green angiography. Br. J. Ophthalmol. 80 3 (1996) 263-266
38. Saxena V., Sadoqi M., and Shao J. Polymeric nanoparticulate delivery system for Indocyanine green: biodistribution in healthy mice. Int. J. Pharm. 308 1-2 (2006) 200-204
39. Monsky W.L., et al. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res. 59 16 (1999) 4129-4135
40. R. Manchanda, A. Fernanderz-Fernanderz, A. Nagesetti, A.J. McGoron, Preparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agents, Colloids Surf. B Biointerfaces (2009), doi:10.1016/j.colsurfb.2009.08.043.